- US FDA approves first cell-based gene therapy for rare genetic skin disorder Dawn
- U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the GlobeNewswire
- Abeona enters commercial gene therapy arena with FDA nod for Zevaskyn to treat rare genetic skin disease Fierce Pharma
- Revolutionary ZEVASKYN Gene Therapy Gets FDA Green Light: First-Ever Treatment for Devastating Skin Disease Stock Titan
- FDA approves pz-cel for recessive dystrophic epidermolysis bullosa Contemporary Pediatrics